Showing results (151-160 of 182) with videos related to

Sort By:
Pageof 19
Case Reports in Nephrology and Urology|December 1, 2012
Immune Complex-Mediated Complement Activation in a Patient with IgG4-Related Tubulointerstitial NephritisSeiji Nagamachi, Isao Ohsawa, Nobuyuki Sato, et al.
Nephron|August 21, 2002
Serum cystatin C is a more sensitive marker of glomerular function than serum creatinineAyumi Shimizu-Tokiwa, Mami Kobata, Hiroaki Io, et al.
Biochemical and Biophysical Research Communications|October 6, 2015
Podocyte-specific deletion of Rac1 leads to aggravation of renal injury in STZ-induced diabetic miceMasanori Ishizaka, Tomohito Gohda, Miyuki Takagi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 15, 2010
Quantitative evaluation and assessment of peritoneal morphologic changes in peritoneal dialysis patientsTetsutaro Shimaoka, Chieko Hamada, Kayo Kaneko, et al.
Journal of Nephrology|May 11, 2013
Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathyHiyori Suzuki, Isao Ohsawa, Fumiko Kodama, et al.
Scientific Reports|March 4, 2017
Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing DialysisTomohito Gohda, Shuntaro Maruyama, Nozomu Kamei, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 3, 2005
Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytesLeyi Gu, Shinji Hagiwara, Qiuling Fan, et al.
Plos One|December 16, 2014
Significance of urinary full-length megalin in patients with IgA nephropathyTakuto Seki, Katsuhiko Asanuma, Rin Asao, et al.
Nephron. Experimental Nephrology|October 16, 2010
Effect of combination therapy with angiotensin receptor blocker and 1,25-dihydroxyvitamin D(3) in type 2 diabetic nephropathy in KK-A(y)/Ta miceIkko Ohara, Mitsuo Tanimoto, Tomohito Gohda, et al.
Pageof 19